Subsequently, we investigated the overall performance of our MLPA cutoff criteria in association with the features typical for oligodendrogliomas (oligodendroglial histology, IDH and TERT mutations and no ATRX loss). The gene discussed is IDH1; the disease is oligodendroglioma.